ClinicalTrials.gg
CompletedNCT05731778Updated Feb 16, 2023

Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis

A Phase 4 interventional study of Stannous Fluoride Toothpaste and Colgate fluoride toothpaste in Gingivitis, sponsored by Colgate Palmolive. Completed at 1 site in Canada. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-16.

Sponsored by Colgate Palmolive · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2018, registered Jul 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 23 studies testing Tin Fluorides in Gingivitis — 1 open to participants now, 3 under way, none of them phase 3. Tin Fluorides · Gingivitis.

Enrollment
23rd of 23
26 · median 115
Started
2018
the only one that year
Phase 4
7 of 23
1 open now
Registered
9th of 23
by date
Lead sponsor
9 of 23
Colgate Palmolive

Among the 23 studies testing Tin Fluorides in Gingivitis, this one is the 23rd largest by enrollment, is the only one that started in 2018, is one of 7 in phase 4, and was the 9th registered.

Gingivitis

631 studies on the registry are indexed under Gingivitis; 107 are open to participants now.

Browse Gingivitis studies →

Open to participants now

1 of the 23 studies testing Tin Fluorides in Gingivitis is open now. Recruiting first, the newest first:

About Tin Fluorides

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger; 11 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies testing Tin Fluorides in Gingivitis, or all of them as a file.
02

Study summary

Evaluate a stannous technology for its effect on the neutrophil phenotype during an induced gingivitis state.

Read the detailed description

A 9-weeks clinical study will be conducted to evaluate a stannous fluoride dentifrice for therapeutic effects that aim to delay the onset of experimental gingivitis as well as hasten the resolution of disease.

03

Conditions studied

  • Gingivitis

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male or female volunteers aged 18-70 years
  2. In good general health,
  3. No clinical signs of gingival inflammation at >90% sites observed
  4. Probing Depth (PD) \< 3.0 mm
  5. Attachment Loss (AL) = 0 mm
  6. No periodontal disease history
  7. Non-smokers
  8. Fluent in English

Exclusion criteria

Exclusion Criteria:

  1. Presence of orthodontic bands.
  2. Presence of partial removal dentures.
  3. Tumour(s) of the soft or the hard tissues of the oral cavity.
  4. Cavitated carious lesions requiring immediate restorative treatment.
  5. History of allergy to consumer or personal care products or dentifrice ingredients as determined by the dental profession monitoring the study.
  6. Participation in any other clinical study or test panel with a one month period prior to entering the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Stannous fluoride test toothpaste

    Currently marketed as the new Colgate Total SF containing Stannous Fluoride

    Drug: Stannous Fluoride Toothpaste

  • Placebo comparator
    Colgate flouride toothpaste

    Colgate Dental Cream containing Stannous Sodium Fluoride

    Drug: Colgate fluoride toothpaste

Interventions

  • 0.454% stannous fluoride toothpaste

    Also known as: Colgate Total SF

  • DrugColgate fluoride toothpaste

    0.76 % Sodium MonoFluorophosphate (MFP)

    Also known as: Colgate Dental Cream

06

What researchers measure

Primary outcomes

  1. Bleeding Index (BOP) and Oral Inflammatory Load

    BOP is a bleeding index standard in field, oral inflammatory load as measured by neutrophil levels in oral rinses

    Time frame: during patient visit over the 9 weeks

07

Study locations

1 site
  • University of Toronto
    Toronto, Ontario M5S, Canada
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2018 to primary completion in Dec 2020, 24 months.

Of 25 phase 4 interventional studies under Gingivitis, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 4. This study's 24 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2019
First posted
Feb 16, 2023
StartActual
Dec 22, 2018
Primary completionActual
Dec 22, 2020
CompletionActual
Dec 22, 2020
Last update
Feb 16, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05731778
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
Feb 16, 2023
Start date
Dec 22, 2018
Primary completion
Dec 22, 2020
Completion
Dec 22, 2020
Last update
Feb 16, 2023

Study contacts

Michael Glogauer, DDS/PhD
principal investigator · University of Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion